OCSIX Fees and Costs — Orchard Small Cap Value Fund, Class I

Data updated: 2020-10-29

The net expense ratio is 1.26%: a 1.14% management fee plus 3.27% other expenses, less a 3.16% fee waiver. There are no sales loads or redemption fees. In fiscal 2019 the fund paid $3K in broker commissions, 0.0492% of average net assets, and portfolio turnover was 16%.

OCSIX Fees and Expenses

Annual operating expenses and sales charges of OCSIX. Prospectus, as of March 31, 2020.

Annual operating expenses
Management fee1.14%
12b-1 fee0.00%
Other expenses3.27%
Gross expense ratio4.42%
Fee waiver−3.16%
Net expense ratio1.26%
Sales charges
Max front load0.00%
Max deferred load0.00%
Redemption fee—
Expense limitation in place (N-CEN)Yes
Fees waived or reduced during the yearYes
Waived fees subject to recoupmentYes

OCSIX Costs Over Time

On $10,000 invested in OCSIX, assuming 5% a year before costs, total costs come to $814 over 5 years, cutting the return by 1.37% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).

$10,000 investedSell after 1 yearSell after 3 yearsSell after 5 years
Value before costs$10,500$11,576$12,763
Fund expenses (net expense ratio 1.26%)$132$411$711
Trading costs (broker commissions)$5$16$28
Lost growth on money paid in costs$0$21$75
Total costs$137$449$814
Value after costs$10,363$11,128$11,949
Impact on return, per year1.37%1.37%1.37%

OCSIX Trading Costs

Brokerage costs reported on SEC Form N-CEN for the fiscal year ending November 30, 2019.

  • Explicit cost rate (commissions ÷ average net assets): 0.0492%
  • Total broker commissions: $3K
  • Bought from dealers (principal trades, not a cost): —
  • Portfolio turnover (prospectus): 16%
  • Securities lending: none during the year

OCSIX Agency Brokers

Commissions paid.

BrokerAmountShare
Fidelity Capital Markets$3K100.00%

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.